microdose tirzepatide Compounded GLP-1 Microdosing Chart: Tirzepatide and

Depending on the test subjects' response and tolerance, consider increasing further to 12.5mg/weekly in weeks 17-20, and to 15mg in weeks 21 and beyond

The strongest predictors of successful dose reduction are behavioral, not genetic

10 (6) e70032

Common patterns from user reports include substantial appetite suppression within the first week or two of treatment, meaningful weight loss averaging around 10% of starting body weight by month three, the phenomenon users describe as a "whoosh" of accelerated weight loss after each dose escalation, and significant psychological relief from constant food-related thoughts